DUBLIN–(BUSINESS WIRE)–The “Cochlear Ltd (COH) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. ThisDUBLIN–(BUSINESS WIRE)–The “Cochlear Ltd (COH) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. This
Cochlear Ltd (COH) Product Pipeline Analysis Report 2025: Portfolio Includes Cochlear Implants, Bone Conduction Systems, Acoustic Implants, and Wireless Accessories – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cochlear Ltd (COH) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufactures, and markets electronic implantable hearing devices. The company’s products suit people with conductive hearing loss, mixed hearing loss or single-sided deafness. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone-anchored prosthetics and wireless accessories.
It has manufacturing facilities in Sweden, China, Malaysia, and Australia. The company markets its products through subsidiaries, local offices, distributors and agents. The company has operations in the Americas; Europe, Middle East and Africa; and Asia-Pacific. Cochlear is headquartered in Sydney, New South Wales, Australia.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cochlear Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Cochlear Ltd, Recent Developments
- Jul 08, 2025: Cochlear Receives FDA Approval for the Cochlear Nucleus Nexa System and Nucleus Kanso 3 and Kanso 3 Nexa Sound Processors
- Jul 08, 2025: Cochlear Launches World’s First and Only Smart Cochlear Implant System
- Jun 20, 2025: Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system
- Jun 14, 2025: Cochlear Bone Anchored Solutions Receives 510(K) Clearance For Baha SoundBand
- Jun 13, 2025: Cochlear Bone Anchored Solutions Receives 510(K) Clearance For Baha 7 Sound Processor
- Jun 12, 2025: Cochlear Launches World’s First and Only Smart Cochlear Implant System With Upgradeable Firmware
- Apr 03, 2025: Cochlear Awaits Clarification on Application of US Tariff
- Jul 02, 2024: Implantable microphone could lead to fully internal cochlear implants
- Jul 02, 2024: Implantable Microphone Could Lead to Fully Internal Cochlear Implants
- Apr 28, 2024: Cochlear Americas Receives Additional 510(K) Clearance For Cochlear Osia System
Key Topics Covered:
- Cochlear Ltd Company Overview
- Cochlear Ltd Company Snapshot
- Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Cochlear Ltd – Pipeline Analysis Overview
- Business Description
- Cochlear Ltd – Key Facts
- Cochlear Ltd – Major Products and Services
- Cochlear Ltd Pipeline Products by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd Pipeline Products Overview
- Cochlear Implant With Dexamethasone Eluting Electrode Array
- Cochlear Implant With Dexamethasone Eluting Electrode Array Product Overview
- Cochlear Implant With Dexamethasone Eluting Electrode Array Clinical Trial
- Cochlear Osia OSI300 Implant
- Cochlear Osia OSI300 Implant Product Overview
- Cochlear Osia OSI300 Implant Clinical Trial
- CP1110 Sound Processor
- CP1110 Sound Processor Product Overview
- Nucleus Profile Plus
- Nucleus Profile Plus Product Overview
- OSIA 2 System
- Product Status
- TI1132 Implant
- TI1132 Implant Product Overview
- TI1132 Implant Clinical Trial
- UmboMic
- UmboMic Product Overview
- Cochlear Ltd – Key Competitors
- Cochlear Ltd – Key Employees
- Cochlear Ltd – Key Employee Biographies
- Cochlear Ltd – Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Appendix
For more information about this company profile visit https://www.researchandmarkets.com/r/l2bke7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Ethereum unveils roadmap focusing on scaling, interoperability, and security at Japan Dev Conference
The post Ethereum unveils roadmap focusing on scaling, interoperability, and security at Japan Dev Conference appeared on BitcoinEthereumNews.com. Key Takeaways Ethereum’s new roadmap was presented by Vitalik Buterin at the Japan Dev Conference. Short-term priorities include Layer 1 scaling and raising gas limits to enhance transaction throughput. Vitalik Buterin presented Ethereum’s development roadmap at the Japan Dev Conference today, outlining the blockchain platform’s priorities across multiple timeframes. The short-term goals focus on scaling solutions and increasing Layer 1 gas limits to improve transaction capacity. Mid-term objectives target enhanced cross-Layer 2 interoperability and faster network responsiveness to create a more seamless user experience across different scaling solutions. The long-term vision emphasizes building a secure, simple, quantum-resistant, and formally verified minimalist Ethereum network. This approach aims to future-proof the platform against emerging technological threats while maintaining its core functionality. The roadmap presentation comes as Ethereum continues to compete with other blockchain platforms for market share in the smart contract and decentralized application space. Source: https://cryptobriefing.com/ethereum-roadmap-scaling-interoperability-security-japan/
Share
BitcoinEthereumNews2025/09/18 00:25
Microsoft Corp. $MSFT blue box area offers a buying opportunity
The post Microsoft Corp. $MSFT blue box area offers a buying opportunity appeared on BitcoinEthereumNews.com. In today’s article, we’ll examine the recent performance of Microsoft Corp. ($MSFT) through the lens of Elliott Wave Theory. We’ll review how the rally from the April 07, 2025 low unfolded as a 5-wave impulse followed by a 3-swing correction (ABC) and discuss our forecast for the next move. Let’s dive into the structure and expectations for this stock. Five wave impulse structure + ABC + WXY correction $MSFT 8H Elliott Wave chart 9.04.2025 In the 8-hour Elliott Wave count from Sep 04, 2025, we saw that $MSFT completed a 5-wave impulsive cycle at red III. As expected, this initial wave prompted a pullback. We anticipated this pullback to unfold in 3 swings and find buyers in the equal legs area between $497.02 and $471.06 This setup aligns with a typical Elliott Wave correction pattern (ABC), in which the market pauses briefly before resuming its primary trend. $MSFT 8H Elliott Wave chart 7.14.2025 The update, 10 days later, shows the stock finding support from the equal legs area as predicted allowing traders to get risk free. The stock is expected to bounce towards 525 – 532 before deciding if the bounce is a connector or the next leg higher. A break into new ATHs will confirm the latter and can see it trade higher towards 570 – 593 area. Until then, traders should get risk free and protect their capital in case of a WXY double correction. Conclusion In conclusion, our Elliott Wave analysis of Microsoft Corp. ($MSFT) suggested that it remains supported against April 07, 2025 lows and bounce from the blue box area. In the meantime, keep an eye out for any corrective pullbacks that may offer entry opportunities. By applying Elliott Wave Theory, traders can better anticipate the structure of upcoming moves and enhance risk management in volatile markets. Source: https://www.fxstreet.com/news/microsoft-corp-msft-blue-box-area-offers-a-buying-opportunity-202509171323
Share
BitcoinEthereumNews2025/09/18 03:50
Gold continues to hit new highs. How to invest in gold in the crypto market?
As Bitcoin encounters a "value winter", real-world gold is recasting the iron curtain of value on the blockchain.
Share
PANews2025/04/14 17:12